BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32781626)

  • 1. Cystic Fibrosis Defective Response to Infection Involves Autophagy and Lipid Metabolism.
    Mingione A; Ottaviano E; Barcella M; Merelli I; Rosso L; Armeni T; Cirilli N; Ghidoni R; Borghi E; Signorelli P
    Cells; 2020 Aug; 9(8):. PubMed ID: 32781626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis.
    Mingione A; Dei Cas M; Bonezzi F; Caretti A; Piccoli M; Anastasia L; Ghidoni R; Paroni R; Signorelli P
    Cell Physiol Biochem; 2020 Jan; 54(1):110-125. PubMed ID: 31999897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myriocin modulates the altered lipid metabolism and storage in cystic fibrosis.
    Signorelli P; Pivari F; Barcella M; Merelli I; Zulueta A; Dei Cas M; Rosso L; Ghidoni R; Caretti A; Paroni R; Mingione A
    Cell Signal; 2021 May; 81():109928. PubMed ID: 33482299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ceramide de novo synthesis by myriocin produces the double effect of reducing pathological inflammation and exerting antifungal activity against A. fumigatus airways infection.
    Caretti A; Torelli R; Perdoni F; Falleni M; Tosi D; Zulueta A; Casas J; Sanguinetti M; Ghidoni R; Borghi E; Signorelli P
    Biochim Biophys Acta; 2016 Jun; 1860(6):1089-97. PubMed ID: 26922830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis.
    Caretti A; Bragonzi A; Facchini M; De Fino I; Riva C; Gasco P; Musicanti C; Casas J; Fabriàs G; Ghidoni R; Signorelli P
    Biochim Biophys Acta; 2014 Jan; 1840(1):586-94. PubMed ID: 24141140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myriocin treatment of CF lung infection and inflammation: complex analyses for enigmatic lipids.
    Caretti A; Vasso M; Bonezzi FT; Gallina A; Trinchera M; Rossi A; Adami R; Casas J; Falleni M; Tosi D; Bragonzi A; Ghidoni R; Gelfi C; Signorelli P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):775-790. PubMed ID: 28439630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of dysfunctional autophagy attenuates hyperinflammatory responses from cystic fibrosis cells.
    Mayer ML; Blohmke CJ; Falsafi R; Fjell CD; Madera L; Turvey SE; Hancock RE
    J Immunol; 2013 Feb; 190(3):1227-38. PubMed ID: 23264659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in
    Schiumarini D; Loberto N; Mancini G; Bassi R; Giussani P; Chiricozzi E; Samarani M; Munari S; Tamanini A; Cabrini G; Lippi G; Dechecchi MC; Sonnino S; Aureli M
    Mediators Inflamm; 2017; 2017():1730245. PubMed ID: 29333001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unravelling the role of sphingolipids in cystic fibrosis lung disease.
    Aureli M; Schiumarini D; Loberto N; Bassi R; Tamanini A; Mancini G; Tironi M; Munari S; Cabrini G; Dechecchi MC; Sonnino S
    Chem Phys Lipids; 2016 Oct; 200():94-103. PubMed ID: 27592248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
    Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
    Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of inflammation by inflammatory mediators in cystic fibrosis lung epithelial cells.
    Tsuchiya M; Kumar P; Bhattacharyya S; Chattoraj S; Srivastava M; Pollard HB; Biswas R
    J Interferon Cytokine Res; 2013 Mar; 33(3):121-9. PubMed ID: 23289731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal activity of Myriocin on clinically relevant Aspergillus fumigatus strains producing biofilm.
    Perdoni F; Signorelli P; Cirasola D; Caretti A; Galimberti V; Biggiogera M; Gasco P; Musicanti C; Morace G; Borghi E
    BMC Microbiol; 2015 Oct; 15():248. PubMed ID: 26519193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid metabolism in cystic fibrosis.
    Worgall TS
    Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):105-9. PubMed ID: 19209467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anoctamin 1 dysregulation alters bronchial epithelial repair in cystic fibrosis.
    Ruffin M; Voland M; Marie S; Bonora M; Blanchard E; Blouquit-Laye S; Naline E; Puyo P; Le Rouzic P; Guillot L; Corvol H; Clement A; Tabary O
    Biochim Biophys Acta; 2013 Dec; 1832(12):2340-51. PubMed ID: 24080196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of miR-155 biogenesis in cystic fibrosis lung epithelial cells: antagonistic role of two mRNA-destabilizing proteins, KSRP and TTP.
    Bhattacharyya S; Kumar P; Tsuchiya M; Bhattacharyya A; Biswas R
    Biochem Biophys Res Commun; 2013 Apr; 433(4):484-8. PubMed ID: 23524258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The basophil surface marker CD203c identifies Aspergillus species sensitization in patients with cystic fibrosis.
    Mirković B; Lavelle GM; Azim AA; Helma K; Gargoum FS; Molloy K; Gernez Y; Dunne K; Renwick J; Murphy P; Moss RB; Greene CM; Gunaratnam C; Chotirmall SH; McElvaney NG
    J Allergy Clin Immunol; 2016 Feb; 137(2):436-443.e9. PubMed ID: 26388311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AR-13 reduces antibiotic-resistant bacterial burden in cystic fibrosis phagocytes and improves cystic fibrosis transmembrane conductance regulator function.
    Assani K; Shrestha CL; Rinehardt H; Zhang S; Robledo-Avila F; Wellmerling J; Partida-Sanchez S; Cormet-Boyaka E; Reynolds SD; Schlesinger LS; Kopp BT
    J Cyst Fibros; 2019 Sep; 18(5):622-629. PubMed ID: 30366849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory role of extracellular sphingolipids in Cystic Fibrosis.
    Zulueta A; Peli V; Dei Cas M; Colombo M; Paroni R; Falleni M; Baisi A; Bollati V; Chiaramonte R; Del Favero E; Ghidoni R; Caretti A
    Int J Biochem Cell Biol; 2019 Nov; 116():105622. PubMed ID: 31563560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation.
    Maiuri L; Luciani A; Giardino I; Raia V; Villella VR; D'Apolito M; Pettoello-Mantovani M; Guido S; Ciacci C; Cimmino M; Cexus ON; Londei M; Quaratino S
    J Immunol; 2008 Jun; 180(11):7697-705. PubMed ID: 18490773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing sphingolipid synthesis orchestrates global changes to extend yeast lifespan.
    Liu J; Huang X; Withers BR; Blalock E; Liu K; Dickson RC
    Aging Cell; 2013 Oct; 12(5):833-41. PubMed ID: 23725375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.